The Patent Finder

Terms ending in 2037

CureVac AG

Every in-force patent on CureVac AG's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,496,335Zika Virus Vaccine
In force
 · High confidence
Sanofi R&D VaccinsIn forceHigh confidence
US 12,258,567Artificial Nucleic Acid Molecules
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 12,460,204Artificial Nucleic Acid Molecules for Improved Protein or Peptide Expression
In force
 · Medium confidence
Curevac SEIn forceMedium confidence
US 12,514,918Nucleic Acid Molecules and Uses Thereof
In force
 · High confidence
CureVac SEIn forceHigh confidence
US 12,527,856Artificial RNA Molecules Encoding a Norovirus Antigen and Uses Thereof
In force
 · High confidence
CureVac SEIn forceHigh confidence
US 10,988,754Novel Nucleic Acid Molecules
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 11,141,474Artificial Nucleic Acid Molecules Encoding a Norovirus Antigen and Uses Thereof
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 12,168,050Compositions Comprising a Norovirus Nucleic Acid and Methods of Use Thereof
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 12,612,654Method for Analyzing RNA
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 12,227,549RNA Encoding a Therapeutic Protein
In force
 · High confidence
Curevac SEIn forceHigh confidence
5 more term ends in 2037 · Pro
10 of 15 patents shown. Soonest term end first, then patent number.
Pro members see all 15.
Upgrade to Pro
14 of these are in force and held by CureVac AG.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited